The SGK3 gene has been reported to be an oestrogen or androgen receptor transcriptional target in ER‐positive breast cancer cells (Wang et al, 2011; Xu et al, 2012) and in androgen receptor (AR)‐positive prostate cancer (Wang et al, 2014). The gene discussed is SGK3; the disease is prostate cancer.